BSEBoard Meeting3d ago · 11 Nov 2026, 05:45 pm
Fischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026 and other allied matters.
Fischer Medical Ventures Ltd · 524743
✦ AI SummaryResults
Fischer Medical Ventures Ltd has scheduled a board meeting on 14th November 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Ltd - 524743 - Board Meeting Intimation for Approval Of Q2 Financial Results And Other Allied Matters.
Attachments (1)
📄pdf
Download →
3b413df4-7f80-4848-901b-98bc9fb8ce18.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
November 11, 2026
BSE Limited National Stock Exchange of India Ltd.
Corporate Relationship Department Exchange Plaza, 5th floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001. Mumbai - 400 051.
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir/ Madam,
Sub: Intimation about the Board Meeting to be held on 14th November 2026
Ref: Regulation 29 of SEBI (LODR) Regulations 2015 as amended
Pursuant to Regulation 29 of the Securities and exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of
Directors of the Company is scheduled to be held on Saturday, the 14th November 2026, through video
conferencing, inter alia,
i) to consider and take on record the unaudited standalone and consolidated financial
results of the company for the quarter and half year ended 30h September 2026,
ii) to transact any other matter as may be specified in the agenda.
As informed earlier vide our letter dated 25th September 2026, the trading window for dealing in the
equity shares of the Company is already closed for all designated persons, their immediate relatives,
other connected persons and shall remain closed until 48 hours after the declaration of the financial
results of the Company for the quarter and half year ended 30th September 2026.
This is for your information and records.
Thanking You,
Yours Truly,
For FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY & COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006